Back to Trades
Tsuchimoto Kim R
DirectorCIK 0001333516
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 17
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Tsuchimoto Kim R, Director, has disclosed $2.1M in transactions — all concentrated in Monopar Therapeutics (MNPR). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.6M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Nov 4 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Sell | $290.1K |
| Aug 28 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Sell | $455.6K |
| Aug 27 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Sell | $455.6K |
| Dec 8 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Award | $222.0K |
| Jul 16 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Sell | $356.2K |
5 filings